Work

Abstract B002: HIF-2A inhibition in adaptive immunity against cancer growth

Year: 2024

Type: conference-abstract

Source: Cancer Immunology Research

DOI: 10.1158/2326-6074.tumimm24-b002

Authors: Katya Frazier, Eric Muise, Joshua Stolz, Lukas Fischer, Mark Buchanan, Charlie Schneider, Brian Pak Ho Chan, Richard Carr, Rodolfo Perini, Brian Long, Douglas Linn

Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403520175

Cites:

Cited by:

Related to: 10